SusanWoodleyRestainoMD
Cardiology • New York, NYHeart Failure & Transplantation
Associate Professor, Medicine, Columbia University College of Phys & Surg
Dr. Restaino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
CUIMC/Vivian & Seymour Milstein Family Heart Center
173 Fort Washington Avenue, Floor 4, Suite 617
New York, NY 10032Phone+1 212-305-7600
Summary
- Dr. Susan Restaino is a cardiologist in New York, NY and is affiliated with New York-Presbyterian Hospital. She received her medical degree from Michigan State University College of Human Medicine and has been in practice 34 years. She specializes in heart failure & transplantation and is experienced in general cardiology, transplant cardiology, heart failure, congestive heart failure, and critical care medicine.
Education & Training
University of Utah HealthFellowship, Cardiovascular Disease, 1986 - 1991
University of California Davis HealthResidency, Internal Medicine, 1984 - 1986
Martinez Veterans Affairs Medical CenterInternship, Internal Medicine, 1983 - 1984
Michigan State University College of Human MedicineClass of 1983
Certifications & Licensure
NY State Medical License 1999 - 2025
CA State Medical License 1984 - 2004- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 1 citationsImpact of preheart transplant spirometry and DCLO measurement on post-transplant pulmonary outcomes.Alice Tao, Jayant Raikhelkar, Luke Benvenuto, Veli K Topkara, Keith Brenner
The Journal of Heart and Lung Transplantation. 2023-06-01 - 1 citationsEarly post-transplant leukopenia in heart transplant recipients and its impact on outcomes.Jaya Batra, Ersilia M DeFilippis, Stephanie Golob, Heidi Lumish, Kevin Clerkin
Clinical Transplantation. 2023-05-01 - 8 citationsPCSK9 inhibitors safely and effectively lower LDL after heart transplantation: a systematic review and meta-analysis.Douglas L Jennings, Lina Sultan, Jennifer Mingov, Jason Choe, Farhana Latif
Heart Failure Reviews. 2023-01-01
Journal Articles
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019Farhana Latif, Maryjane A Farr, Kevin J Clerkin, Koji Takeda, Yoshifumi Naka, Susan Restaino, Gabriel Sayer, Nir Uriel, JAMA Cardiology
- Engaging Hospital Patients in the Medication Reconciliation Process Using Tablet ComputersSuzanne Bakken, Demetra Tsapepas, Susan Restaino, Journal of the American Medical Informatics Association
Authored Content
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
- Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
- Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
